Raritan Bay Medical Center

rbmc.org

Raritan Bay Medical Center, a member of the Meridian Health Family, is a not-for-profit community hospital with locations in Old Bridge and Perth Amboy. Raritan Bay is one of a few hospitals in the world to achieve Magnet Recognition for nursing excellence three times. The hospital is a New Jersey state-designated primary stroke center, a recipient of the American Stroke Association Get with the Guidelines® - Stroke Silver Plus, American Heart Association’s Heart Failure Gold and Mission: Lifeline® EMS Silver Performance Achievement Awards recognizing high quality care of stroke and heart failure patients and patients experiencing a severe heart attack, respectively…

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Digital Healthcare

HERO AND ADHEREHEALTH ESTABLISH STRATEGIC PARTNERSHIP TO IMPROVE MEDICATION ADHERENCE AMONG VULNERABLE PATIENTS

AdhereHealth | December 18, 2021

news image

AdhereHealth, a healthcare technology leader in medication adherence insights and health outcomes, has entered into a strategic partnership with Hero, the market leader in digital in-home care. This new agreement enables AdhereHealth to deploy Hero's digital in-home care platform to help high-risk, high-cost, chronically ill patients adhere to complex medication regimens. Hero's platform includes a connected smart pill dispenser, which automatically sorts and dispenses medic...

Read More

Health Technology

ANTENGENE ANNOUNCES ATG-101 GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA

Antengene Corporation Limited | September 19, 2022

news image

Antengene Corporation Limited a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematology and oncology, announced that ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, has been granted an Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. This ODD will help Antenge...

Read More

AI

MAXWELL HEALTHCARE ASSOCIATES AND SELECT DATA UNITE TO SOLVE CODING & DOCUMENTATION CHALLENGES USING (AI) ARTIFICIAL INTELLIGENCE

Maxwell Healthcare Associates | February 04, 2022

news image

Maxwell Healthcare Associates (MHA), the industry's leading post-acute operational, financial, technological and regulatory consulting firm, and Select Data, a leading healthcare AI and outsourcing company, announce a partnership to optimize the post-acute space with high-quality coding and clinical documentation review processes. Select Data leverages the power of artificial intelligence (AI) to transform post-acute documentation review and coding to achieve quality...

Read More

Health Technology

CUE HEALTH PROVIDES ENHANCED CARE & PROTECTION FOR IMMUNOCOMPROMISED POPULATIONS & CLINICAL CARE TEAMS AT FRESENIUS KIDNEY CARE

Cue Health Inc. | August 25, 2022

news image

Cue Health Inc. a healthcare technology company announced a new collaboration with Fresenius Kidney Care to provide the most accurate* COVID-19 self-test to certain patients and clinical care teams. People who are immunocompromised have been disproportionately affected by COVID-19 throughout the pandemic and remain highly dependent on measures that reduce the likelihood of infections, including vaccination. Cue can be used by vulnerable patient populations and their care partners to...

Read More
news image

Digital Healthcare

HERO AND ADHEREHEALTH ESTABLISH STRATEGIC PARTNERSHIP TO IMPROVE MEDICATION ADHERENCE AMONG VULNERABLE PATIENTS

AdhereHealth | December 18, 2021

AdhereHealth, a healthcare technology leader in medication adherence insights and health outcomes, has entered into a strategic partnership with Hero, the market leader in digital in-home care. This new agreement enables AdhereHealth to deploy Hero's digital in-home care platform to help high-risk, high-cost, chronically ill patients adhere to complex medication regimens. Hero's platform includes a connected smart pill dispenser, which automatically sorts and dispenses medic...

Read More
news image

Health Technology

ANTENGENE ANNOUNCES ATG-101 GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA

Antengene Corporation Limited | September 19, 2022

Antengene Corporation Limited a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematology and oncology, announced that ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, has been granted an Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. This ODD will help Antenge...

Read More
news image

AI

MAXWELL HEALTHCARE ASSOCIATES AND SELECT DATA UNITE TO SOLVE CODING & DOCUMENTATION CHALLENGES USING (AI) ARTIFICIAL INTELLIGENCE

Maxwell Healthcare Associates | February 04, 2022

Maxwell Healthcare Associates (MHA), the industry's leading post-acute operational, financial, technological and regulatory consulting firm, and Select Data, a leading healthcare AI and outsourcing company, announce a partnership to optimize the post-acute space with high-quality coding and clinical documentation review processes. Select Data leverages the power of artificial intelligence (AI) to transform post-acute documentation review and coding to achieve quality...

Read More
news image

Health Technology

CUE HEALTH PROVIDES ENHANCED CARE & PROTECTION FOR IMMUNOCOMPROMISED POPULATIONS & CLINICAL CARE TEAMS AT FRESENIUS KIDNEY CARE

Cue Health Inc. | August 25, 2022

Cue Health Inc. a healthcare technology company announced a new collaboration with Fresenius Kidney Care to provide the most accurate* COVID-19 self-test to certain patients and clinical care teams. People who are immunocompromised have been disproportionately affected by COVID-19 throughout the pandemic and remain highly dependent on measures that reduce the likelihood of infections, including vaccination. Cue can be used by vulnerable patient populations and their care partners to...

Read More

Resources

resource image

Digital Healthcare, Medical Devices

Portrait Mobile Monitoring Solution

Video

resource image

Healthcare Analytics

Beyond the Bottom Line

Whitepaper

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us